Marker Therapeutics, Inc.
Developing T Cell Immunotherapies
- B2C
About Marker Therapeutics, Inc.
A clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematological malignancies and solid tumor indications using non-engineered, tumor-specific T cells
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11–50 employees
- Headquarters
- houston, texas, United States
- Founded
- 2018
- Revenue
- $9.2M – $52.6MTamtam estimate
- Website
- markertherapeutics.com
Marker Therapeutics, Inc. at a glance
Marker Therapeutics, Inc. is a B2C company in the Pharmaceutical Manufacturing industry, headquartered in houston, texas, United States.
Marker Therapeutics, Inc. was founded in 2018.
Marker Therapeutics, Inc. has 11–50 employees.
Marker Therapeutics, Inc.'s revenue is $9.2M – $52.6M (Tamtam estimate).
Selling to companies like Marker Therapeutics, Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies